The first Abattis Bioceuticals trade was made in Q1 2021.
Since then Ken Fisher bought shares two more times and sold shares on three occasions. The investor completely sold their stake between Q2 2022 and Q4 2022.
Avg closing price
Price range
Sold -24.4 Thousand shares
Q4 2022
Avg closing price
$0.00
Price range
$0.00
-
$0.00
Sold 0.0% shares (-4 shares)
Q2 2022
Avg closing price
$0.00
Price range
$0.00
-
$0.00
Increased shares by 22.0% (+4.4 Thousand shares)
Q1 2022